Closed · HR001123S0037 · CFDA 12.910 · Discretionary
Synthetic Hemo-technologIEs to Locate and Disinfect (SHIELD)
Federal grant opportunity posted by DARPA - Biological Technologies Office, cataloged on Grants.gov.
- Varies
- Award range
- Closed
- Status
- September 27, 2023
- Close date
- -
- Expected awards
The verdict
Synthetic Hemo-technologIEs to Locate and Disinfect (SHIELD) is a closed discretionary listing from DARPA - Biological Technologies Office that offered Varies by applicant. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 73 other opportunities from DARPA - Biological Technologies Office.
- Varies
- award range
- Closed
- application status
- 12.910
- CFDA program
- 73
- other opportunities from DARPA - Biological Technologies Office
Archived opportunity record
Synthetic Hemo-technologIEs to Locate and Dis… is closed (last close September 27, 2023). Check the agency catalog for replacement NOFOs. DARPA - Biological Technologies Office still indexes 73 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed September 27, 2023
Instrument
Procurement Contract
Description
The Synthetic Hemo-technologIEs to Locate and Disinfect (SHIELD) program will develop safe and effective prophylactic countermeasures to defeat bloodborne pathogens and prevent bloodstream infections (BSI) associated with combat wounds. The program will develop prophylactic countermeasures effective against both bacteria and fungi, pathogens that are responsible for the vast majority of BSI. State-of-the-art countermeasures to manage BSI include antifungals and antibiotics which can be toxic, ineffective, and be administered in an untimely manner. SHIELD will develop safe and effective broad-spectrum prophylaxes that will protect recipients from bloodborne bacteria and fungi and prevent BSI for up to 144 h.
Catch-all / unrestricted eligibility mark · HR001123S0037
Grants.gov marks Synthetic Hemo-technologIEs to Locate and Dis… with a catch-all / unrestricted eligibility code (Others (see official listing text)). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Procurement Contract. Funding-activity code maps to Science and Technology / R&D (ST). This eligibility-code string dominates the DARPA - Biological Technologies Office book (44 peers, 59% of 74).
- Code 25
- Others (see official listing text)
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
BAA Coordinator SHIELD@darpa.mil
More from DARPA - Biological Technologies Office
What to do next
Synthetic Hemo-technologIEs to Locate and Dis… is closed; use the parent program and agency catalog for the next funding cycle.
- Browse open federal opportunities in the same category when this listing is closed. Open opportunities
- Look up CFDA 12.910 across all indexed listings before you commit to this opportunity alone. Eligibility finder
- Compare award ranges across federal categories before you pick a single CFDA. All categories
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |